Bioject Medical Technologies Inc. (BJCT) Key Ratios

Profile for Bioject Medical Technologies Inc.  (BJCT) 
$ 0.045   0.005 (+12.50%) Volume: 6 k 9:56 AM EST Feb 10, 2012
Income Statements
Revenue (LTM) ($): 8.99 m
Revenue per Share (LTM) ($): 0.48
Revenue per Employee (LTM) ($): 272,539.94
Revenue Growth 3 Yr: 5.09%
Revenue Growth 5 Yr: -6.97%
 
Dividends & Splits
Annual Dividend Rate ($): N/A
Annual Dividend Yield: N/A
Dividend Growth 3 Yr: N/A
Dividend Growth 5 Yr: N/A
Ex-Dividend Date: N/A
Payment Type: N/A
Financial Strength (LTM)
Quick Ratio: 0.80
Current Ratio: 1.20
Long Term Debt to Total Capital: N/A
Total Debt to Equity: N/A
Interest Coverage: 16.70
Leverage Ratio: N/A
 
Profitability (LTM)
Gross Margin: 45.40%
EBIT Margin: 5.60%
EBITDA Margin: 8.40%
Pre-Tax Profit Margin: -43.90%
Profit Margin (Cont. Op): 5.30%
Profit Margin (Total Op): 5.30%
Management Effectiveness LTM 5 Yr Avg
Return on Equity N/A N/A
Return on Capital -142.90% -142.90%
Return on Assets -49.90% -49.90%
 
Assets
Asset Turnover: 2.10
Inventory Turnover: 5.20
Receivable Turnover: 12.50
Valuation Measures
P/E Ratio: N/A
P/E High - Last 5 Years: N/A
P/E Avg. High - Last 5 Years: N/A
P/E Low - Last 5 Years: N/A
P/E Avg. Low - Last 5 Years: N/A
 
Price to Sales: 0.08
Price to Book: N/A
Price to Tangible Book: -0.10
Price to Cash Flow: 1.00
Price to Free Cash: 1.30